Cardionics, Inc.
Classification
Private
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
About
About
Cardionics, Inc. is a privately-held company that offers auscultation products and services that facilitate and support classroom education, clinical, and tele-health programs in medical institutions and universities around the world. The company offers various learning systems for teaching and learning critical auscultation and clinical skills in classrooms, simulation labs, and online; and clinical systems that include a line of electronic stethoscopes and accessories for physicians to amplify, record, play back, and analyze a patient's physiological sounds. It also provides tele-health systems for sending and receiving patient's physiological sounds, such as the heart, breath, and bowel sounds from remote or rural locations to a physician or hospital over the Internet. Cardionics, Inc. was founded in 1969. Cardionics, Inc. headquarters are located in Webster, Texas. Cardionics, Inc. was formerly known as Excellus Technologies, Inc.
Keywords
Keywords
Classified
Private